Drug Shortage Report for MEFENAMIC
Report ID | 234154 |
Drug Identification Number | 02229452 |
Brand name | MEFENAMIC |
Common or Proper name | Mefenamic Acid |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MEFENAMIC ACID |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | M01AG |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-08-05 |
Actual start date | |
Estimated end date | 2024-08-30 |
Actual end date | 2024-09-04 |
Shortage status | Resolved |
Updated date | 2024-09-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-09-05 | English | Compare |
v11 | 2024-09-04 | French | Compare |
v10 | 2024-09-04 | English | Compare |
v9 | 2024-08-22 | French | Compare |
v8 | 2024-08-22 | English | Compare |
v7 | 2024-08-19 | French | Compare |
v6 | 2024-08-19 | English | Compare |
v5 | 2024-08-08 | French | Compare |
v4 | 2024-08-08 | English | Compare |
v3 | 2024-08-06 | English | Compare |
v2 | 2024-07-31 | French | Compare |
v1 | 2024-07-31 | English | Compare |
Showing 1 to 12 of 12